Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.

@article{McDougle1998SertralineIA,
  title={Sertraline in adults with pervasive developmental disorders: a prospective open-label investigation.},
  author={Christopher J. McDougle and Edward S. Brodkin and Stephanie Naylor and Dr. Michelle C. Carlson and Donald J. Cohen and Lawrence H. Price},
  journal={Journal of clinical psychopharmacology},
  year={1998},
  volume={18 1},
  pages={62-6}
}
The short-term efficacy and tolerability of sertraline for adults with pervasive developmental disorders (PDDs) were assessed in this investigation. Forty-two adults with PDDs (autistic disorder, N = 22; Asperger's disorder, N = 6; and PDD not otherwise specified [NOS], N = 14) participated in a 12-week, open-label, systematic trial of sertraline. Behavioral ratings of repetitive symptoms, aggression, and social relatedness were obtained at baseline and after 4, 8, and 12 weeks of sertraline… CONTINUE READING
22 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…